Dongkook struggles to reverse decline in Insadol sales

Dongkook Pharm has strived to boost the sluggish sales of Insadol, a top-selling OCT medicine for treatment of gingival disease, by providing better wholesaler’s margin.

The company is hoping to find sales-boosting measures to regain its leadership in the domestic market, through a closer collaboration with wholesalers and pharmacists.

The Korea and Food and Administration reaffirmed that...